Quality management specification for drug clinical trials

On:
In: Medicine/medical devices, NMPA
On May 6, the national medical product administration and the national health and Health Commission issued the new “quality management specification for drug clinical trials”, which is applicable to drug clinical trials for drug registration, and shall come into force as of July 1, 2020.  Clinical trials of drugs should conform to the principles of the declaration of Helsinki of the world medical congress and relevant ethical requirements. The documents that should be reviewed by the Ethics Committee include: the trial scheme and the revised trial scheme; informed consent and its updates; ways and information of recruiting the subjects; otherRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is ＄5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114

Existing Users Log In
   
New User Registration
*Required field

Related posts:

  1. Pharmacovigilance quality management specification
  2. Clinical trial for new drug registration in China 2021
  3. Class III medical devices subject to clinical trials 2020
  4. Implementation of Drug Administration Law
  5. Clinical technical requirements for overseas listed drugs
  6. Measures for clinical use of medical devices
  7. Measures for the administration of drug registration 2020
  8. Regulations of Clinical New Biomedical Technologies Application
  9. China issued specification for drug traceability code identification
  10. Management requirements for drug record and data-Trial